Yi Lin, MD, PhD

Yi Lin, MD, PhD, is a hematologist and oncologist with a clinical practice in lymphoma, multiple myeloma and cell therapy. Her current apointment is at the Mayo Clinic as a co-chair, Novel Immunotherapy Working Committee, International Myeloma Working Group, International Myeloma Foundation, member, Clinical Oncology Study Section, National Institutes of Health, and grant reviewer, Leukemia and Lymphoma Society.

Articles

Excitement Around Cilta-Cel in Multiple Myeloma

Yi Lin, MD, PhD

September 21st 2023

Yi Lin MD, PhD, discusses the impact of the phase 1b/2 CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of relapsed or refractory multiple myeloma.

Lin Reviews Long-Term Results from CARTITUDE-1

Yi Lin, MD, PhD

September 10th 2023

Yi Lin MD, PhD, discusses long-term follow-up results from the CARTITUDE-1 study, which investigated ciltacabtagene autoleucel for the treatment of relapsed or refractory multiple myeloma.

Lin Reviews Data on Cilta-Cel in Multiple Myeloma

Yi Lin, MD, PhD

August 15th 2023

Yi Lin MD, PhD explains how results from CARTITUDE-1 impact the treatment landscape for relapsed or refractory multiple myeloma.